Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Annual Information Update

16th Jul 2009 11:58

RNS Number : 7912V
BTG PLC
16 July 2009
 



For immediate release

Annual Information Update 2009

BTG plc (LSE: BGC) ("the Company") is pleased to provide its annual information update, in accordance with the requirements of the Prospectus Rule 5.2. This update refers to information that has been published or made available by the Company to the public over the twelve months ending today. To avoid an unnecessarily lengthy document, information is referred to in this update rather than included in full.

The information referred to in this update was up to date at the time the information was published but some information may now be out-of-date. 

 

(1) Announcements made via RNS, a Regulatory Information Service

All of the documents listed below were published via RNS, a Regulatory Information Service on or around the dates indicated.

 

Date of publication

Brief description of announcement 

15 July 2009

Results of AGM

15 July 2009

2009 AGM and Interim Management Statement

9 July 2009

Notification of major interest in BTG plc shares

7 July 2009

Total voting rights and share capital

19 June 2009

Notification of 2009 Annual Report and Accounts and AGM documents filed with UKLA

3 June 2009

Notification of major interest in BTG plc shares

29 May 2009

Total voting rights and share capital

14 May 2009

Preliminary results statement for the year ended 31 March 2009

8 May 2009

Notification of major interest in BTG plc shares

5 May 2009

Notification of major interest in BTG plc shares

5 May 2009

Notification of major interest in BTG plc shares

1 May 2009

Notice of results

30 April 2009

Total voting rights and share capital

21 April 2009

Block Listing Return

2 April 2009

Close period update

31 March 2009

Total voting rights and share capital

23 January 2009

Directors' Interests in shares of BTG plc

22 January 2009

Interim management statement

12 January 2009

Notification of major interest in BTG plc shares

7 January 2009

Notification of major interest in BTG plc shares

2 January 2009

Total voting rights and share capital

10 December 2008

Notification of major interest in BTG plc shares

10 December 2008

Notification of major interest in BTG plc shares

10 December 2008

Directors' Interests in shares of BTG plc

8 December 2008

Notification of major interest in BTG plc shares

8 December 2008

Notification of major interest in BTG plc shares

5 December 2008

Notification of major interest in BTG plc shares

5 December 2008

Notification of major interest in BTG plc shares

4 December 2008

Completion of acquisition of Protherics PLC

1 December 2008

Total voting rights and share capital

20 November 2008

BTG licensee Cougar Biotechnology initiates phase I/II trial of CB7630 (Abiraterone Acetate) in advanced breast cancer

17 November 2008

Notification of major interest in BTG plc shares

12 November 2008

Interim results statement for half year ended 30 September 2008

7 November 2008

BTG licenses novel anticancer compound to Onyx Pharmaceuticals

7 November 2008

Results of Varisolve® US phase II safety study to be presented at ACP

5 November 2008

Result of EGM

28 October 2008

Notice of interim results

23 October 2008

Final phase II results of Campath® multiple sclerosis study published

17 October 2008

BTG plc and Protherics PLC Offer Update - Posting of Scheme Document/Receipt of Letters of Intent

16 October 2008

BTG plc and Protherics PLC Offer Update - Intended date of posting of Offer Documents

1 October 2008

Block Listing Return

30 September 2008

Total voting rights and share capital

22 September 2008

Directors' Interests in shares of BTG plc

18 September 2008

Recommended all share offer by BTG plc for Protherics PLC 

29 August 2008

Total voting rights and share capital

6 August 2008

Tolerx initiates dosing of otelixizumab in a phase III clinical trial in type I diabetes

31 July 2008

Total voting rights and share capital

22 July 2008

Study shows Abiraterone can successfully treat aggressive chemotherapy-resistant prostate cancer

16 July 2008

2008 AGM and interim management statement

16 July 2008

Results of 2008 AGM

11 July 2008

Annual Information Update 2008

Copies of the above announcements can be downloaded from the Company's website (www.btgplc.com) or obtained from the Company Secretary at the Company's Registered Office, 5 Fleet PlaceLondonEC4M 7RD.

 

(2) Documents filed at Companies House

All of the documents listed below were filed with Companies House in Cardiff on or around the dates indicated.

 

Date of filing

Brief description of document

11 July 2009

2009 Annual Report and Accounts filed

9 July 2009

Form 88(2) allotment of shares re share option exercise

6 June 2009

Form 88(2) allotment of shares re share option exercise

13 May 2009

Form 288a Appointment of Director - William James O'Shea

1 May 2009

Form 88(2) allotment of shares re share option exercise

15 April 2009

Form 288a Appointment of Secretary - Rolf Soderstrom

9 April 2009

Form 288b Resignation of Director and Secretary - Christine Soden

3March 2009

Form 88(2) allotment of shares re share option exercise

31 March 2009

Form 288c Change of Director's details - Louise Makin

31 March 2009

Form 288c Change of Director's details - Rolf Soderstrom

31 March 2009

Form 288c Change of Director's details - Christine Soden

25 March 2009

Form 287 Change of registered office address

23 December 2008

Form 363a Annual Return

19 December 2008

Form 88(2) allotment of shares re share option exercise

16 December 2008

Form 288a Appointment of Director - Rolf Soderstrom

1 December 2008

Form 88(2) allotment of shares re share option exercise

5 November 2008

Ordinary and Special Resolutions relating to the acquisition of Protherics PLC

2 October 2008

Filing of new articles of association

30 September 2008

Form 88(2) allotment of shares re share option exercise

29 August 2008

Form 88(2) allotment of shares re share option exercise

1 August 2008

Form 88(2) allotment of shares re share option exercise

17 July 2008

Form 288b Resignation of Director - Alison Wood

17 July 2008

Form 288b Resignation of Director - Carol Consuelo Brooke

17 July 2008

Filing of new articles of association and special resolutions passed at AGM

Copies of documents filed at Companies House can be obtained from Companies House or obtained from the Company Secretary at the Company's Registered Office, 5 Fleet Place, London, EC4M 7RD.

CONTACT:

Andy Burrows

Director of Investor Relations

Telephone: 020 7575 1741

16 July 2009

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIUCKAKPKBKDQOD

Related Shares:

BTG
FTSE 100 Latest
Value8,496.80
Change1.95